Fastnet Equity PLC Potential Acquisition and Statement re Suspension (6703P)
February 22 2016 - 2:30AM
UK Regulatory
TIDMFAST
RNS Number : 6703P
Fastnet Equity PLC
22 February 2016
Fastnet Equity plc
("Fastnet" or the "Company")
22 February 2016
Potential Acquisition and Statement re Suspension
On 28 August 2015, Fastnet shareholders voted to adopt an
investing policy focussed on acquiring companies or businesses in
the healthcare sector particularly those in the biopharma sector.
The Company now announces that it is in very advanced discussions
with Amryt Pharmaceuticals DAC (the "Acquisition"). If the
Acquisition proceeds, the enlarged group will become a late stage,
specialty biopharmaceutical company and will constitute a reverse
takeover in accordance with Rule 14 of the AIM Rules for Companies
and Rule 14 of the ESM Rules for Companies.
Accordingly, the Company has requested that its ordinary shares
be suspended from trading on AIM and ESM, with immediate effect,
pending either publication of an admission document containing
detailed information on the Acquisition or the termination of the
proposed Acquisition.
A further announcement will be made in due course.
Enquiries:
Fastnet Oil & Gas plc C/o FTI Consulting
Harry Stratford, Non-Executive
Director
+44 (0) 20
Shore Capital 7408 4090
Nomad and Joint Broker
Bidhi Bhoma, Edward Mansfield
+353 (1) 679
Davy 6363
ESM Adviser and Joint
Broker
John Frain, Anthony Farrell
+44 (0) 20
FTI Consulting 3727 1000
Simon Conway
This information is provided by RNS
The company news service from the London Stock Exchange
END
SRSDMGZZGMVGVZZ
(END) Dow Jones Newswires
February 22, 2016 02:30 ET (07:30 GMT)
Fastnet Equity (LSE:FAST)
Historical Stock Chart
From Oct 2024 to Nov 2024
Fastnet Equity (LSE:FAST)
Historical Stock Chart
From Nov 2023 to Nov 2024